Unclear Diagnoses in Patients with Metastatic Disease

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
October 14, 2014

New Data Coming Out of ASCO

Hear Dr. Michaelis describe the new data coming out of ASCO regarding polycythemia vera including new medicine.Supported through funding from Incyte

July 13, 2021

Occurrence of TRK Fusion–Positive Tumors in Different Cancer Types

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, confer on the categorization of various cancer types in which NTRK gene fusions may be detected.